These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30690796)

  • 1. Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen's disease in clinical practice: A retrospective cohort study (2006-2017).
    Aguilar-Bernier M; Rodríguez-Barón D; Rivas-Ruiz F; Segura-Palacios JM; de Troya Martín M
    Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):208-213. PubMed ID: 30690796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for cutaneous Bowen's disease.
    Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
    Kim HJ; Song KH
    J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Bowen's disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL).
    Alique-García S; Alique D; Company-Quiroga J; Sánchez A; Núñez AH; Borbujo J
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():192-194. PubMed ID: 31398515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
    Aguilar M; de Troya M; Martin L; Benítez N; González M
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
    Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
    An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions.
    Gómez C; Cobos M; Alberdi E
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():295-299. PubMed ID: 30986539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
    Ibbotson SH; Valentine R; Hearn R
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
    Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
    Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of sequential therapy in digital Bowen's disease with methyl aminolevulinate photodynamic therapy and topical diclofenac 3% in hyaluronan 2.5% gel.
    Gracia-Cazaña T; López MT; Oncins R; Gilaberte Y
    Dermatol Ther; 2015; 28(6):341-3. PubMed ID: 26291609
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up of metil aminolevulinate (MAL)-PDT in difficult-to-treat cutaneous Bowen's disease.
    Cavicchini S; Serini SM; Fiorani R; Girgenti V; Ghislanzoni M; Sala F
    Int J Dermatol; 2011 Aug; 50(8):1002-5. PubMed ID: 21781078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
    Farhi D; Bedane C; Savary J; Basset-Seguin N
    Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How we treat Bowen's disease with topical photodynamic therapy in Dundee.
    Attili SK; Ibbotson SH
    Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):41-5. PubMed ID: 19447370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in the treatment of extensive Bowen's disease.
    López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
    J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periocular photodynamic therapy for squamous intra-epidermal carcinoma.
    Casie Chetty N; Hemmant B; Skellett AM
    J Dermatolog Treat; 2014 Dec; 25(6):516-8. PubMed ID: 24215518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl aminolevulinate photodynamic therapy for Bowen's disease on the fingers-Is monotherapy sufficiently effective?
    Repelnig ML; Weger W; Cerpes U; Wolf P; Legat FJ
    Photodermatol Photoimmunol Photomed; 2020 Nov; 36(6):487-489. PubMed ID: 32623780
    [No Abstract]   [Full Text] [Related]  

  • 20. Photodynamic therapy for subungual Bowen's disease.
    Tan B; Sinclair R; Foley P
    Australas J Dermatol; 2004 Aug; 45(3):172-4. PubMed ID: 15250896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.